Cargando…
Aberrant expression and potency as a cancer immunotherapy target of alpha-methylacyl-coenzyme A racemase in prostate cancer
Alpha-methylacyl-CoA racemase (AMACR) is an enzyme playing an important role in the beta-oxidation of branched-chain fatty acids and fatty acid derivatives. High expression levels of AMACR have been described in various cancers, including prostate cancer, colorectal cancer and kidney cancer. Because...
Autores principales: | Honma, Ichiya, Torigoe, Toshihiko, Hirohashi, Yoshihiko, Kitamura, Hiroshi, Sato, Eiji, Masumori, Naoya, Tamura, Yasuaki, Tsukamoto, Taiji, Sato, Noriyuki |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2797764/ https://www.ncbi.nlm.nih.gov/pubmed/20003233 http://dx.doi.org/10.1186/1479-5876-7-103 |
Ejemplares similares
-
Significance of overexpression of alpha methylacyl-coenzyme A racemase in hepatocellular carcinoma
por: Li, Wei, et al.
Publicado: (2008) -
Alpha-methylacyl-coenzyme A racemase expression in neuroendocrine neoplasms of the stomach
por: Annenkov, Alexey, et al.
Publicado: (2012) -
Alpha-Methylacyl-Coenzyme A Racemase-Expressing Urachal Adenocarcinoma of the Abdominal Wall
por: Ha, Yun-Sok, et al.
Publicado: (2010) -
Potential Survival Benefit of Anti-Apoptosis Protein: Survivin-Derived Peptide Vaccine with and without Interferon Alpha Therapy for Patients with Advanced or Recurrent Urothelial Cancer—Results from Phase I Clinical Trials
por: Tanaka, Toshiaki, et al.
Publicado: (2013) -
Increased expression of α-methylacyl-coenzyme A racemase (AMACR; p504s) and p16 in distal hyperplastic polyps
por: Dayi, Nimet, et al.
Publicado: (2013)